Referências

Abdel-Fattah S (2006) Non Invasive Prenatal Diagnosis. ASJOG 3: 80-83.

Ammicuci P et al (2000) Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem. 46: 301-302.

Chiu RWK et al (2002a) Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin. Chem 48:778-780.

Chiu RWK et al (2002b) Prenatal exclusion of ß thalassemia major by examination of maternal plasma. Lancet 360: 998-1000.

Costa JM et al (2002) New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 346(19): 1502.

Daniels G et al (2007) Fetal RhD genotyping: A more efficient use of anti-D immunoglobulin. Transf Clin Biol 14: 568-571.

Farina A et al (2003) Evaluation of cell-free fetal DNA as a second trimester maternal serum marker of Down syndrome pregnancy. Clin. Chem. 49: 239-242.

Finning K et al (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336: 816-818.

Finning K et al (2004) A Clinical Service n the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. N.Y. Acad.Sci 1022: 119-123.

González-González MC et al (2002) Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat. Diagn 22:946-948.

Hahn S et al (2008) Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonat Med 13: 57-62.

Levi JE et al (2003) Determinação Pré-natal do Sexo Fetal por meio da análise de DNA no Plama Materno – Prenatal Fetal Gender Determination by Analysis of DNA from Maternal Plasma. RBGO 25(9):687-690.

Leung TN et al (2001) Increased maternal plasma fetal DNA concentration in women who eventually develop preeclampsia. Clin. Chem. 47: 137-139.

Levine RJ et al (2004) Two stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am. J. Obstet.Gyneco. 190(3):707-13.

Li Y et al (2007) Non-invasive prenatal detection of achondroplasia in size-fractioned cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 27: 11-17.

Lo YMD et al (2007) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. PNAS 104(32): 13116-13121.

Lo YM et al (1999) Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64: 218-224.

Lo YM et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non invasive prenatal diagnosis. Am. J. Hum. Genet. 62:768-755.

Norbury G & Norbury CJ (2008) Non-invasive prenatal diagnosis of single gene disorder: How close are we? Semin Fetal Neonat Med 13: 76-83.

Rijnders RJP et al (2004) Cell-free fetal DNA is not present in plasma of non-pregnant mothers. Clin. Chem. 20:679-681.

Saito H et al (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 365: 1170

Tungwiwat W et al (2007) Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-ß-thalassemia. Translat Res 150(5):319-325

Wataganara T, Bianchi DW (2004) Fetal Cell-free nucleic acids in the maternal circulation. Ann. N.Y. Acad. Sci. 1022:1-10.

Zhong XY et al (2000)Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20: 795-798.

Zolotukhina TV et al (2005) Analysis of Cell-free DNA in Plasma and Serum of Pregnant Women. J Histoch Cytoch 53(3): 297-299.